Clinical Trial Update: A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With Chronic Bronchitis Experiencing Rapid Onset of Worsening of Symptoms Caused by Bacteria [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial comparing levofloxacin with cefaclor for treatment of chronic bronchitis in adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis

Drugs mentioned

• Cefaclor (Ceclor) (Cefaclor)
• Levofloxacin (Levaquin) (Levofloxacin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Bronchitis, Bronchitis, Chronic | Phase 2, Phase 3 | Status: COMPLETED